No Data
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Needham Sticks to Its Hold Rating for Staar Surgical (STAA)
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $39
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $39
Staar Surgical (STAA) Receives a Buy From BTIG